These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
972 related articles for article (PubMed ID: 23040455)
41. Diagnostic steps in the evaluation of patients with erectile dysfunction. Hatzichristou D; Hatzimouratidis K; Bekas M; Apostolidis A; Tzortzis V; Yannakoyorgos K J Urol; 2002 Aug; 168(2):615-20. PubMed ID: 12131320 [TBL] [Abstract][Full Text] [Related]
42. Erectile dysfunction in the cardiovascular patient. Vlachopoulos C; Jackson G; Stefanadis C; Montorsi P Eur Heart J; 2013 Jul; 34(27):2034-46. PubMed ID: 23616415 [TBL] [Abstract][Full Text] [Related]
43. [Erectile dysfunction and incontinence after prostatectomy. Treating the complications of surgery for prostate cancer]. Schout B; Meuleman EJ Ned Tijdschr Geneeskd; 2012; 156(44):A4667. PubMed ID: 23114170 [TBL] [Abstract][Full Text] [Related]
49. Newer phosphodiesterase inhibitors: comparison with established agents. McNamara ER; Donatucci CF Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082 [TBL] [Abstract][Full Text] [Related]
50. Erectile dysfunction. Shabsigh R; Anastasiadis AG Annu Rev Med; 2003; 54():153-68. PubMed ID: 12525671 [TBL] [Abstract][Full Text] [Related]
51. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors. Liu DF; Jiang H; Hong K; Zhao LM; Tang WH; Ma LL Chin Med J (Engl); 2010 Nov; 123(22):3258-61. PubMed ID: 21163126 [TBL] [Abstract][Full Text] [Related]
52. Organic causes of erectile dysfunction in men under 40. Ludwig W; Phillips M Urol Int; 2014; 92(1):1-6. PubMed ID: 24281298 [TBL] [Abstract][Full Text] [Related]
53. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer. Albaugh JA Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854 [TBL] [Abstract][Full Text] [Related]
54. Bicycle riding, perineal trauma, and erectile dysfunction: data and solutions. Goldstein I; Lurie AL; Lubisich JP Curr Urol Rep; 2007 Nov; 8(6):491-7. PubMed ID: 18042330 [TBL] [Abstract][Full Text] [Related]
55. Erectile dysfunction management for the future. Burnett AL J Androl; 2009; 30(4):391-6. PubMed ID: 18802198 [TBL] [Abstract][Full Text] [Related]
56. Interactions between lower urinary tract symptoms and cardiovascular risk factors determine distinct patterns of erectile dysfunction: a latent class analysis. Barbosa JA; Muracca E; Nakano É; Assalin AR; Cordeiro P; Paranhos M; Cury J; Srougi M; Antunes AA J Urol; 2013 Dec; 190(6):2177-82. PubMed ID: 23727187 [TBL] [Abstract][Full Text] [Related]
57. [Levitra (oral dispersible tablet)--an innovative drug for the treatment of patients with erectile dysfunction]. Korneev IA Urologiia; 2013; (2):106-8, 110-1. PubMed ID: 23789375 [TBL] [Abstract][Full Text] [Related]
58. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Dorsey P; Keel C; Klavens M; Hellstrom WJ Expert Opin Pharmacother; 2010 May; 11(7):1109-22. PubMed ID: 20402554 [TBL] [Abstract][Full Text] [Related]
59. MODERN ENDOVASCULAR TREATMENT METHODS FOR ERECTILE DYSFUNCTION: A CRITICAL ANALYSIS. Piegza M; Paterak M; Błachut M; Piegza J Wiad Lek; 2020; 73(9 cz. 2):2049-2055. PubMed ID: 33148858 [TBL] [Abstract][Full Text] [Related]
60. [Cardiovascular diseases and erectile dysfunction]. Pomeshkina SA; Pomeshkin EV; Barbarash OL; Neĭmark AI Ter Arkh; 2010; 82(10):37-40. PubMed ID: 21341462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]